COVID-19 Co-infection in a patient with Crimean Congo Hemorrhagic Fever: A Case Report

Basit Öğe Kaydı
dc.authoridOz, Murtaza/0000-0003-3415-5927
dc.authoridhasbek, mursit/0000-0002-5217-8607
dc.authoridBakir, Mehmet/0000-0003-3702-1932
dc.authoridBUYUKTUNA, SEYIT ALI/0000-0001-6518-7361
dc.contributor.authorBuyuktuna, Seyit Ali
dc.contributor.authorHasbek, Mursit
dc.contributor.authorOksuz, Caner
dc.contributor.authorBaysal, Cihad
dc.contributor.authorOz, Murtaza
dc.contributor.authorElaldi, Nazif
dc.contributor.authorBakir, Mehmet
dc.date.accessioned2024-10-26T18:00:18Z
dc.date.available2024-10-26T18:00:18Z
dc.date.issued2021
dc.departmentSivas Cumhuriyet Üniversitesi
dc.description.abstractCrimean-Congo Hemorrhagic Fever (CCHF) is an acute viral zoonotic disease. Coronavirus disease-2019 (COVID-19) is a newly emerging viral disease and it is caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In this article, a case diagnosed with CCHF and COVID-19 coinfection confirmed by the polymerase chain reaction (PCR) method and its management was presented. A thirty-five years old female patient admitted to the hospital with the complaint of fever for one day and common body pain. It was learned that three days before the onset of her complaints, she removed a tick adhering to the anterior abdominal wall with no precaution. Her body temperature was 38 degrees C degrees and her respiratory rate was 22 per minute. The leucocyte count was 3660/mm(3) and the platelet count was 138.000/mm(3). It was determined that prothrombin time was 15.4 seconds, international normalized ratio (INR) was 1.35 seconds, and D-dimer level was 1310 ng/ml. The patient was hospitalized with prediagnosis of CCHF. Supportive treatment was started. On the second day at the clinical follow-up of the patient, complaints of sore throat and cough without sputum started. A combined nasopharyngeal and throat swab sample was taken from the patient because of the suspicion of COVID-19. COVID-19 PCR test result was reported as positive. Favipiravir treatment was started. The CCHF-PCR test, which was studied from the serum sample sent to the Microbiology Reference Laboratories was reported as positive. From the third day of favipiravir treatment; the patient did not have a fever and her complaints regressed. On the ninth day of her hospitalization, she was discharged. In this case; it is important to show that both diseases, especially in regions where CCHF disease is endemic, can be confused due to the similarity of the clinical picture with COVID-19 and to know that they can coexist.
dc.identifier.doi10.5578/mb.20219813
dc.identifier.endpage451
dc.identifier.issn0374-9096
dc.identifier.issue3
dc.identifier.pmid34416809
dc.identifier.scopus2-s2.0-85111530160
dc.identifier.scopusqualityQ4
dc.identifier.startpage445
dc.identifier.trdizinid445463
dc.identifier.urihttps://doi.org/10.5578/mb.20219813
dc.identifier.urihttps://search.trdizin.gov.tr/tr/yayin/detay/445463
dc.identifier.urihttps://hdl.handle.net/20.500.12418/27624
dc.identifier.volume55
dc.identifier.wosWOS:000674351200013
dc.identifier.wosqualityQ4
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakTR-Dizin
dc.indekslendigikaynakPubMed
dc.language.isotr
dc.publisherAnkara Microbiology Soc
dc.relation.ispartofMikrobiyoloji Bulteni
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectCo-infection
dc.subjectCOVID-19
dc.subjectCCHF
dc.titleCOVID-19 Co-infection in a patient with Crimean Congo Hemorrhagic Fever: A Case Report
dc.typeArticle

Dosyalar

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayınlar Koleksyonu
Scopus İndeksli Yayınlar Koleksiyonu
TR-Dizin İndeksli Yayınlar Koleksiyonu